Clinical Trial on Agitation in Alzheimer's Dementia

NCT05543681 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Agitation,Psychomotor
Care Giving Burden
NPS
Aggression

Interventions

DRUG: IGC-AD1-Active
DRUG: IGC-AD1-Placebo

Sponsor

IGC Pharma, LLC